We think you’ll love these
Melrose FutureLab NAD+ Booster 30 Capsules
About this item
Product Overview
Product at a glance
- Bottom line
- NAD+ booster capsule in a 30-count bottle for adults who prefer a clean, one-capsule daily supplement routine.
- What it is
- A capsule supplement with nicotinamide riboside chloride, LipiSperse NR, and dimethylglycine hydrochloride, supplied in a 30-capsule bottle for daily use.
- Why people choose it
- Chosen for its focused ingredient profile, one-capsule format, and practical bottle size that supports tidy routine planning and repeat purchase timing.
- How it’s used
- Adults take one capsule daily with water, or follow directions provided by their health professional.
Melrose FutureLab NAD+ Booster 30 Capsules
Melrose FutureLab NAD+ Booster delivers a targeted cellular support formula designed to enhance the body’s natural NAD+ (nicotinamide adenine dinucleotide) levels — a coenzyme vital for energy production and cellular health. As we age, NAD+ levels naturally decline; this TGA-listed formula combines nicotinamide riboside chloride (NR) — a direct precursor to NAD+ — with dimethylglycine and advanced LipiSperse® technology to support mitochondrial energy, cellular repair, and healthy ageing.
Active: Nicotinamide Riboside (NR) — not NMN
Crafted for discerning wellness consumers, the capsules are vegan-friendly, free from gluten and dairy, and suitable for daily use. With one capsule per day, you can integrate this advanced supplement into your longevity routine — whether your goal is to maintain vitality, optimise recovery, or support healthy ageing.
Sustainability & Quality
Melrose FutureLab formulates with integrity: each batch meets stringent TGA-listed standards and is Australian made and owned. Every ingredient is chosen for purity, bioavailability, and scientific validation — reflecting Melrose’s evidence-based, science-first approach to cellular nutrition.
TGA Listed Medicine — ARTG ID: 447700 (Melrose FutureLab NAD+ Booster). Listed actives: Nicotinamide Riboside Chloride and Dimethylglycine Hydrochloride. This product is included in the Australian Register of Therapeutic Goods as a Listed Medicine under the Therapeutic Goods Act 1989.
This AUST number (447700) identifies the product on the Australian Register of Therapeutic Goods (ARTG).
